McKesson has renewed its distribution agreement with its largest client, CVS Health, the drug distributor announced during its earnings call May 9, according to Reuters.
The previous agreement was set to expire in June 2019. The renewed contract will run through 2023.
McKesson is the major distributor for the CVS pharmacy benefit unit, CVS Caremark.